Published 2025-01-01
“…Jenny Skumsnes Moe,1,2 Jørgen G Bramness,1–
4 Ingeborg Bolstad,1,5 Jørg Gustav Mørland,3,6 Philip Gorwood,7,8 Nicolas Ramoz7,8 1Research Center for Substance Use Disorders and Mental Illness, Innlandet Hospital Trust, Brumunddal, Norway; 2Institute for Clinical Medicine, The Arctic
University of Norway, Tromsø, Norway; 3Department of Alcohol, Tobacco, and Drugs, Norwegian Institute of Public Health, Oslo, Norway;
4Section for Clinical Addiction Research, Oslo
University Hospital, Oslo, Norway; 5Department of Health and Social Science, Inland Norway
University of Applied Sciences, Elverum, Norway; 6Institute of Clinical Medicine,
University of Oslo, Oslo, Norway; 7Université
Paris Cité, Inserm U1266, Institut de Psychiatrie et Neurosciences de
Paris (IPNP), Team Vulnerability of Psychiatric and Addictive Disorders,
Paris, France; 8GHU
PARIS Psychiatrie & Neurosciences, Hôpital Sainte-Anne, CMME,
Paris, FranceCorrespondence: Jenny Skumsnes Moe, Research Center for Substance Use Disorders and Mental Illness, Innlandet Hospital Trust, P.O. …”
Get full text
Article
